- Madrigal Pharmaceuticals Inc MDGL shares rose 33.9 percent to $29.90.
- Ascendis Pharma A/S ASND shares climbed 31.7 percent to $36.52. Wedbush raised price target on Ascendis Pharma from $36 to $65 following Versartis data.
- TDH Holdings Inc PETZ shares surged 19.5 percent to $7.45. TDH Holdings priced IPO at $4.25 per share.
- China Lending Corp CLDC shares rose 17 percent to $2.94.
- ITUS Corp ITUS shares surged 16 percent to $2.38.
- Alpine Immune Sciences, Inc. ALPN climbed 9.9 percent to $10.64. Stifel Nicolaus upgraded Alpine Immune Sciences from Hold to Buy.
- StoneMor Partners L.P. STON shares gained 8.9 percent to $6.61. StoneMor Partners promoted two executives to key management positions. The company named Ken Lee as National Vice-President of Operations, and Gina Mack as Vice-President of Human Resources.
- Veru Inc VERU shares jumped 8.8 percent to $2.22.
- RADA Electronic Ind. Ltd. RADA shares rose 8.7 percent to $3.48.
- Finish Line Inc FINL climbed 8.2 percent to $9.97. Finish Line reported Q2 adjusted earnings of $0.12 per share on revenue of $469.4 million.
- MINDBODY Inc MB shares gained 7.9 percent to $26.80. KeyBanc upgraded MINDBODY from Sector Weight to Overweight.
- CarMax, Inc KMX jumped 6.3 percent to $73.20 after the company reported stronger-than-expected results for its second quarter.
- Equifax Inc. EFX surged 5.3 percent to $103.45. Wells Fargo upgraded Equifax from Market Perform to Outperform.
- Aldeyra Therapeutics Inc ALDX shares climbed 4.9 percent to $8.34 after the company reported closing of public offering of 3,967,500 shares of common stock and full exercise of option to purchase additional shares.
- AstraZeneca plc (ADR) AZN rose 3.3 percent to $33.90. Bernstein upgraded AstraZeneca from Market Perform to Outperform.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in